Mereo BioPharma Income Statement (2017-2026) | MREO

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.01B0.00B0.00B
Gross Profit (Quarter) -0.00B0.01B-0.00B0.00B0.00B
Operating items
Research & Development (Quarter) 0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.00B0.00B0.00B
Selling, General & Administrative (Quarter) 0.01B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.00B
Other Operating Expenses (Quarter) -0.01B-0.00B0.00B0.00B
Operating Expenses (Quarter) 0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.01B
Operating Income (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B0.04B-0.01B-0.01B-0.01B-0.01B-0.01B
EBIT (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B0.04B-0.01B-0.01B-0.01B-0.01B-0.01B
Non-operating items
Non Operating Investment Income (Quarter) 0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B0.00B
Interest & Investment Income (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter) -0.00B-0.00B
Non Operating Income (Quarter) -0.00B-0.00B
Net income details
EBT (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Tax Provisions (Quarter) 0.00B
Profit After Tax (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Income from Continuing Operations (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Consolidated Net Income (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Income towards Parent Company (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Net Income towards Common Stockholders (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Additional items
EPS (Basic) (Quarter) -0.020.00-0.01-0.01-0.01-0.02-0.02-0.01-0.02-0.02-0.01-0.01-0.01
EPS (Weighted Average and Diluted) (Quarter) -0.020.00-0.01-0.01-0.01-0.02-0.02-0.01-0.02-0.02-0.01-0.01-0.01
Shares Outstanding (Weighted Average) (Quarter) 0.09B91.55B0.11B0.45B0.71B0.71B0.62B0.63B0.68B0.66B0.70B0.77B0.73B0.74B0.78B0.80B0.80B0.80B0.80B
Shares Outstanding (Diluted Average) (Quarter) 0.71B0.62B0.63B0.65B0.66B0.70B0.77B0.73B0.74B0.78B0.80B0.80B0.80B0.80B
EBITDA (Quarter) -0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Interest Expenses (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Shares Outstanding (Quarter) 0.09B0.13B0.45B0.79B0.00B0.00B0.64B0.70B0.70B0.70B0.77B0.77B0.78B0.80B0.80B0.80B0.80B0.80B
Tax Rate (Quarter) -5.52